As shown in Fig. 8A, combination treatment with Lexa (1 μg/ml) and CHX (10 μg/ml) induced caspase 8 activation in HCC cells, but not in normal human hepatocytes. The gene discussed is CASP8; the disease is hepatocellular carcinoma.